Mostrando 10 resultados de: 16
Filtros aplicados
Publisher
Clinical Pharmacology and Therapeutics(2)
Anales de Medicina Interna(1)
British Journal of Clinical Pharmacology(1)
European Journal of Cancer and Clinical Oncology(1)
European Journal of Clinical Pharmacology(1)
Área temáticas
Enfermedades(8)
Bioquímica(3)
Fisiología humana(3)
Factores que afectan al comportamiento social(1)
Fisiología y materias afines(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(12)
ODS 10: Reducción de las desigualdades(10)
ODS 9: Industria, innovación e infraestructura(6)
ODS 17: Alianzas para lograr los objetivos(5)
ODS 12: Producción y consumo responsables(1)
Origen
scopus(16)
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
ArticleAbstract: In a previous study we showed that the disposition of clozapine after a single oral dose is unrelatePalabras claves:Autores:Adrián LLerena, Alm C., Benitez Rodriguez J., Bertilsson L., Bondesson U., Carrillo J., Dahl M.L., Lindstrom L., Ramos S., Rodriguez de la Rubia I.Fuentes:scopusAcetylator polymorphism in Parkinson's disease
ArticleAbstract: Acetylator phenotype has been determined using sulphamethazine in 100 patients with Parkinson's disePalabras claves:acetylator phenotype, debrisoquine oxidation, drug polymorphism, Parkinsonism, sulphamethazineAutores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J., Fernandez-Gundin M.J., Jimenez F.J., Ladero J.M., Martinez C., Muñoz J.J.Fuentes:scopusDEBRISOQUINE HYDROXYLATION PHENOTYPES IN HEALTHY VOLUNTEERS
OtherAbstract:Palabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J.Fuentes:scopusDebrisoquin oxidation polymorphism in a Spanish population
ArticleAbstract: The capacity for debrisoquin metabolism was determined in 377 healthy Spanish volunteers by measurinPalabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J.Fuentes:scopusDebrisoquine oxidation in schizophrenic patients treated with neuroleptics
ArticleAbstract:Palabras claves:debrisoquine, Neuroleptics, OXIDATION, SchizophreniaAutores:Adrián LLerena, Benitez Rodriguez J., Buemi A.L., Caputi A.P., Cobaleda J., García M.A., Piña B., Spina E.Fuentes:scopusDebrisoquine oxidation phenotype in psychiatric patients.
ArticleAbstract:Palabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J., García M.A., Martínez C., Piñas B.Fuentes:scopusInfluence of genetic admixture on polymorphisms of drug-metabolizing enzymes: Analyses of mutations on NAT2 and CYP2E1 genes in a mixed Hispanic population
ArticleAbstract: Objectives and study design: The genetic basis of two polymorphisms of drug- and carcinogen-metaboliPalabras claves:Autores:Adrián LLerena, Agúndez J.A.G., Benitez Rodriguez J., Hernandez M., Martínez C., Olivera M., Ramirez R.Fuentes:scopusInteraction between prajmaline and metoprotol: a possible pharmacogenetic explanation
OtherAbstract:Palabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Berecz R.Fuentes:scopusInterethnic differences in drug metabolism: Influence of genetic and environmental factors on debrisoquine hydroxylation phenotype
Conference ObjectAbstract: Genetic and environmental factors are determinants of the interindividual and interethnic variabilitPalabras claves:CYP2D6, debrisoquine, gender, pharmacogenetics, smokingAutores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J., Martínez C.Fuentes:scopusReproducibility over Time of Mephenytoin and Debrisoquine Hydroxylation Phenotypes
ArticleAbstract: Mephenytoin and debrisoquine hydroxylation phenotypes were determined twice in 15 Spanish healthy voPalabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Bertilsson L., Valdivielso M.J.Fuentes:scopus